Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Patterson

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Vaccine|August 23, 2013
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing scheduleGail L Rodgers, Susanna Esposito, Nicola Principi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2018
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) StudyAnna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
Nature Medicine|June 13, 2006
Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiencyAntonio M Almeida, Yoshiko Murakami, D Mark Layton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Anna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
JMIR Research Protocols|September 6, 2022
Proactive, Recovery-Oriented Treatment Navigation to Engage Racially Diverse Veterans in Mental Healthcare (PARTNER-MH), a Peer-Led Patient Navigation Intervention for Racially and Ethnically Minoritized Veterans in Veterans Health Administration Mental Health Services: Protocol for a Mixed Methods Randomized Controlled Feasibility StudyJohanne Eliacin, Diana J Burgess, Angela L Rollins, et al.
The Pediatric Infectious Disease Journal|September 27, 2012
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given to korean children receiving routine pediatric vaccinesDong Soo Kim, Seon Hee Shin, Hoan Jong Lee, et al.
Pediatrics|March 18, 2015
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infantsFederico Martinón-Torres, Hanna Czajka, Kimberly J Center, et al.
Vaccine|March 7, 2017
A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinationsJacek Wysocki, Kimberly J Center, Jerzy Brzostek, et al.
Seikagaku. the Journal of Japanese Biochemical Society|December 8, 2004
[From genome to proteome--aim of human proteomics]Kazuyuki Nakamura, Ruedi Aebersold, Amos Bairoch, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Vaccine|August 23, 2013
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing scheduleGail L Rodgers, Susanna Esposito, Nicola Principi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2018
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) StudyAnna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
Nature Medicine|June 13, 2006
Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiencyAntonio M Almeida, Yoshiko Murakami, D Mark Layton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Anna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
JMIR Research Protocols|September 6, 2022
Proactive, Recovery-Oriented Treatment Navigation to Engage Racially Diverse Veterans in Mental Healthcare (PARTNER-MH), a Peer-Led Patient Navigation Intervention for Racially and Ethnically Minoritized Veterans in Veterans Health Administration Mental Health Services: Protocol for a Mixed Methods Randomized Controlled Feasibility StudyJohanne Eliacin, Diana J Burgess, Angela L Rollins, et al.
The Pediatric Infectious Disease Journal|September 27, 2012
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given to korean children receiving routine pediatric vaccinesDong Soo Kim, Seon Hee Shin, Hoan Jong Lee, et al.
Pediatrics|March 18, 2015
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infantsFederico Martinón-Torres, Hanna Czajka, Kimberly J Center, et al.
Vaccine|March 7, 2017
A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinationsJacek Wysocki, Kimberly J Center, Jerzy Brzostek, et al.
Seikagaku. the Journal of Japanese Biochemical Society|December 8, 2004
[From genome to proteome--aim of human proteomics]Kazuyuki Nakamura, Ruedi Aebersold, Amos Bairoch, et al.
Pageof 7